Comments on:

Obama's fiscal cliff drug 'reform' idea will backfire

Back to the article » |
As part of the fiscal cliff negotiations, the White House has trotted out a deeply misguided healthcare idea. The President has his allies want to loosen "intellectual property" protection for an advanced class of pharmaceuticals called "biologics." This is a mistake. Including this plan in any federal budget deal would inevitably undermine drug innovation, compromise care for millions of...

To learn more about commenting on WashingtonExaminer.com and our community guidelines, please see our comments FAQ.